Former Bristol-Myers Exec Gets 1 Year For Insider Trading

Law360, New York (October 23, 2013, 4:11 PM EDT) -- A former Bristol-Myers Squibb Co. executive on Wednesday was sentenced in New Jersey federal court to 366 days in prison for insider trading after admitting to purchasing stock options in a biotechnology company he knew BMS was preparing to acquire.

Robert Ramnarine pled guilty in June to a count of securities fraud before U.S. District Judge Anne E. Thompson, who sentenced Ramnarine to a year and a day in federal prison followed by two years of supervised release. The judge also ordered Ramnarine to pay a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.